Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
PharmaShots
Top 20 Prescription Drugs of 2026
Shots: 20. Vyndaqel Family Non-Proprietary Name: Tafamidis Company: Pfizer First Approved: US (Nov 13, 2015), EU (Feb 1, 2016) Total Revenue: $6.38B 19. Prevnar Family Non-Proprietary Name: Pneumococcal Conjugate Vaccines Company: Pfizer First Approved: US (Nov 13, 2015), EU (Feb 1, 2016) Total Revenue: $6.49B 18. Cosentyx Non-Proprietary Name: Upadacitinib Company: Novartis First Approved: US (Jan… The post Top 20 Prescription Drugs of 2026 appeared first on PharmaShots.
Read Full Article
Pharma Tech
HIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir
Though yet to be finalised, the initial recommendation would mean the injectable PrEP would not be covered on the NHS.
Read Full Article
Pharma Tech
ERS 2026: BMI, type-2 inflammation, and asthma attack risk
At ERS 2026, investigators reported their findings from their review of the Oxford Asthma Attack Risk Scale Meta-Analysis (ORACLE2).
Read Full Article
Pharma Tech
Staunch biotech competition spurs new secretive tactics, shifts investor approach
Biotechs and investors are increasingly altering their strategies amid changes in the development and commercial landscape.
Read Full Article
Pharma Tech
Exegenesis Bio and Modalis sign research deal for Duchenne therapy
Exegenesis Bio and Modalis Therapeutics have entered into a research partnership and licence agreement to progress MDL-201, a therapeutic candidate for DMD.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Sep 14, 2026, 2:29 AM
Sun Pharma reaches settlement in US antitrust case over generic drugp Pricing
The company said its US subsidiaries, Sun Pharma Inc. and Taro Pharmaceuticals, will make the settlement payment in exchange for a full release of all claims asserted against them.
ET Pharma
Sep 14, 2026, 2:00 AM
Aurobindo Pharma’s API facility clears FDA inspection
The Unit-IV operated by the company’s wholly owned subsidiary, Apitoria Pharma, was inspected from September 7 to September 11.
ET Pharma
Sep 12, 2026, 2:00 AM
Alembic Pharma's Vadodara bioequivalence facility clears USFDA inspection
In a regulatory filing, the company said the United States Food and Drug Administration (USFDA) carried out the onsite bioequivalence inspection from August 31, 2026, to September 10, 2026.
ET Pharma
Sep 12, 2026, 1:55 AM
GSK to shut vaccine factory in Germany, putting 641 jobs at risk
The closure would put 641 jobs at risk, according to German trade union Industriegewerkschaft Bergbau, Chemie, Energie (IGBCE).
PharmaShots
Sep 11, 2026, 1:30 PM
Top 20 Prescription Drugs of 2026
Shots: 20. Vyndaqel Family Non-Proprietary Name: Tafamidis Company: Pfizer First Approved: US (Nov 13, 2015), EU (Feb 1, 2016) Total Revenue: $6.38B 19. Prevnar Family Non-Proprietary Name: Pneumococcal Conjugate Vaccines Company: Pfizer First Approved: US (Nov 13, 2015), EU (Feb 1, 2016) Total Revenue: $6.49B 18. Cosentyx Non-Proprietary Name: Upadacitinib Company: Novartis First Approved: US (Jan… The post Top 20 Prescription Drugs of 2026 appeared first on PharmaShots.
Pharma Tech
Sep 11, 2026, 1:10 PM
HIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir
Though yet to be finalised, the initial recommendation would mean the injectable PrEP would not be covered on the NHS.
News
Latest industry coverage
Google News
Sep 14, 2026, 3:30 AM
Monday Motivation: 'Entrepreneurship is about staying the course' - Livemint
Monday Motivation: 'Entrepreneurship is about staying the course' Livemint
Google News
Sep 14, 2026, 3:18 AM
Canberra details tax changes with limited concessions for some innovators - BiotechDispatch
Canberra details tax changes with limited concessions for some innovators BiotechDispatch
Google News
Sep 14, 2026, 2:10 AM
Aptar Pharma Expands Preservative Free Technology Production in Latin America - BioSpace
Aptar Pharma Expands Preservative Free Technology Production in Latin America BioSpace
Google News
Sep 14, 2026, 1:51 AM
Smart Pharmaceutical Packaging Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight - The National Law Review
Smart Pharmaceutical Packaging Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight The National Law Review
Google News
Sep 14, 2026, 1:11 AM
AI-Driven Pharmaceutical R&D Infrastructure Competition: Key Trends, Strategies & Industry Impact - 36 Kr
AI-Driven Pharmaceutical R&D Infrastructure Competition: Key Trends, Strategies & Industry Impact 36 Kr
Google News
Sep 14, 2026, 12:39 AM
SK Biopharmaceuticals Earns Top MSCI ESG Rating for Third Year - Seoul Economic Daily
SK Biopharmaceuticals Earns Top MSCI ESG Rating for Third Year Seoul Economic Daily
Google News
Sep 14, 2026, 12:25 AM
SK Biopharmaceuticals Becomes First Korean Pharma to Earn ‘AAA’ MSCI ESG Rating - 아시아경제
SK Biopharmaceuticals Becomes First Korean Pharma to Earn ‘AAA’ MSCI ESG Rating 아시아경제
Google News
Sep 14, 2026, 12:00 AM
Smart Pharmaceutical Packaging Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight - EIN News
Smart Pharmaceutical Packaging Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight EIN News
Google News
Sep 13, 2026, 10:33 PM
Trump's secretive pharma deals may undermine 'most-favored nation' pricing, an analysis suggests - STAT
Trump's secretive pharma deals may undermine 'most-favored nation' pricing, an analysis suggests STAT
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer